Interactions between circRNAs and miR-141 in cancer: from pathogenesis to diagnosis and therapy
M Guz, W Jeleniewicz, M Cybulski - International Journal of Molecular …, 2023 - mdpi.com
The function of non-coding RNAs (ncRNAs) in the pathogenesis and development of cancer
is indisputable. Molecular mechanisms underlying carcinogenesis involve the aberrant …
is indisputable. Molecular mechanisms underlying carcinogenesis involve the aberrant …
Improving whole tomato transformation for prostate health: benign prostate hypertrophy as an exploratory model
PG Natali, M Piantelli, M Minacori, M Eufemi… - International Journal of …, 2023 - mdpi.com
It is well-established that the beneficial properties of single phytonutrients can be better
attained when they are taken with the complex of the molecules present in their natural …
attained when they are taken with the complex of the molecules present in their natural …
[HTML][HTML] Targeting benign prostate hyperplasia treatments: AR/TGF-β/NOX4 inhibition by apocynin suppresses inflammation and proliferation
BR Jin, HJ Kim, JH Na, WK Lee, HJ An - Journal of Advanced Research, 2024 - Elsevier
Abstract Introduction Apocynin (Apo), an NADPH oxidase (NOX) inhibitor, has been widely
used to treat various inflammatory diseases. However, the therapeutic effects of Apo on …
used to treat various inflammatory diseases. However, the therapeutic effects of Apo on …
ANO7 African-ancestral genomic diversity and advanced prostate cancer
J Jiang, PXY Soh, SBA Mutambirwa… - Prostate Cancer and …, 2023 - nature.com
Abstract Background Prostate cancer (PCa) is a significant health burden for African men,
with mortality rates more than double global averages. The prostate specific Anoctamin 7 …
with mortality rates more than double global averages. The prostate specific Anoctamin 7 …
Personalized medicine in a community health system: The NorthShore experience
SP David, HM Dunnenberger, S Choi… - Frontiers in …, 2023 - frontiersin.org
Genomic and personalized medicine implementation efforts have largely centered on
specialty care in tertiary health systems. There are few examples of fully integrated care …
specialty care in tertiary health systems. There are few examples of fully integrated care …
Future aspects of plant derived bioactive metabolites as therapeutics to combat benign prostatic hyperplasia
R Krishnamoorthi, A Kumaran - Journal of Ethnopharmacology, 2024 - Elsevier
Ethnopharmacological relevance Benign prostatic hyperplasia (BPH), characterized by
prostate enlargement due to cell proliferation, is a common urinary disorder in men over 50 …
prostate enlargement due to cell proliferation, is a common urinary disorder in men over 50 …
Polygenic risk score predicting susceptibility and outcome of benign prostatic hyperplasia in the Han Chinese
SC Hung, LW Chang, TH Hsiao, GC Lin, SS Wang… - Human Genomics, 2024 - Springer
Background Given the high prevalence of BPH among elderly men, pinpointing those at
elevated risk can aid in early intervention and effective management. This study aimed to …
elevated risk can aid in early intervention and effective management. This study aimed to …
ANO7 African-ancestral genomic diversity and advanced prostate cancer
BACKGROUND: Prostate cancer (PCa) is a significant health burden for African men, with
mortality rates more than double global averages. The prostate specific Anoctamin 7 (ANO7) …
mortality rates more than double global averages. The prostate specific Anoctamin 7 (ANO7) …